Forward Pharma FA ApS: Financial statements 2019
CVR: 37281603
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Forward Pharma FA ApS (CVR 37281603) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -30,944 and a net result of DKK -34,096 compared with DKK -27,673 the year before. Equity in the 2019 report amounted to DKK 9,599. The solvency ratio was 1.3%.
- Gross Profit
- DKK -30,944
- Profit/Loss
- DKK -34,096
- Equity
- DKK 9,599
- Total Assets
- DKK 714,751
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -31 t. | -34 t. | 10 t. | - |
| 2018 | - | -25 t. | -28 t. | -56 t. | - |
| 2017 | - | -569 t. | -447 t. | -29 t. | - |
| 2016 | - | -2.2 mio. | -1.7 mio. | 419 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Forward Pharma FA ApS has published its annual report for 2018. Gross profit came to DKK -25,125, and the net result was DKK -27,673.
About Forward Pharma FA ApS
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 27 October 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283.